Literature DB >> 20102486

New oral antithrombotics: a need for laboratory monitoring. For.

P Mismetti1, S Laporte.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20102486     DOI： 10.1111/j.1538-7836.2010.03764.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  15 in total

1.  [New anticoagulant drugs for atrial fibrillation. Feasibility and necessity of monitoring].

Authors:  K Madlener; C Hamm
Journal:  Herz       Date:  2012-06       Impact factor: 1.443

Review 2.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  New oral anticoagulants in non-valvular atrial fibrillation.

Authors:  Pietro Francia; Carmen Adduci; Daria Santini; Beatrice Musumeci; Giuliano Tocci
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-05-08

Review 4.  Measuring the anticoagulant effects of target specific oral anticoagulants-reasons, methods and current limitations.

Authors:  Helen Mani; Alexander Kasper; Edelgard Lindhoff-Last
Journal:  J Thromb Thrombolysis       Date:  2013-08       Impact factor: 2.300

5.  Glomerular filtration rate estimated by Cockcroft-Gault formula better predicts anti-Xa levels than modification of the diet in renal disease equation in older patients with prophylactic enoxaparin.

Authors:  B Dufour; M Toussaint-Hacquard; A Kearney-Schwartz; M D P Manckoundia; M C Laurain; L Joly; J Deibener; D Wahl; T Lecompte; A Benetos; C Perret-Guillaume
Journal:  J Nutr Health Aging       Date:  2012-07       Impact factor: 4.075

6.  Large inter-individual variation of the pharmacodynamic effect of anticoagulant drugs on thrombin generation.

Authors:  Saartje Bloemen; H Coenraad Hemker; Raed Al Dieri
Journal:  Haematologica       Date:  2012-10-25       Impact factor: 9.941

7.  Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability.

Authors:  Job Harenberg; Roland Krämer; Christina Giese; Svetlana Marx; Christel Weiss; Martin Wehling
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

8.  Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital setting.

Authors:  Ekta Yogeshkumar Pandya; Elizabeth Anderson; Clara Chow; Yishen Wang; Beata Bajorek
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

9.  Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

Authors:  Rickard E Malmström; Brian B Godman; Eduard Diogene; Christoph Baumgärtel; Marion Bennie; Iain Bishop; Anna Brzezinska; Anna Bucsics; Stephen Campbell; Alessandra Ferrario; Alexander E Finlayson; Jurij Fürst; Kristina Garuoliene; Miguel Gomes; Iñaki Gutiérrez-Ibarluzea; Alan Haycox; Krystyna Hviding; Harald Herholz; Mikael Hoffmann; Saira Jan; Jan Jones; Roberta Joppi; Marija Kalaba; Christina Kvalheim; Ott Laius; Irene Langner; Julie Lonsdale; Sven-Äke Lööv; Kamila Malinowska; Laura McCullagh; Ken Paterson; Vanda Markovic-Pekovic; Andrew Martin; Jutta Piessnegger; Gisbert Selke; Catherine Sermet; Steven Simoens; Cankat Tulunay; Dominik Tomek; Luka Vončina; Vera Vlahovic-Palcevski; Janet Wale; Michael Wilcock; Magdalena Wladysiuk; Menno van Woerkom; Corrine Zara; Lars L Gustafsson
Journal:  Front Pharmacol       Date:  2013-05-14       Impact factor: 5.810

10.  New oral anticoagulants - a practical guide.

Authors:  Tomasz Ciurus; Sebastian Sobczak; Anna Cichocka-Radwan; Malgorzata Lelonek
Journal:  Kardiochir Torakochirurgia Pol       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.